Robert Tjian's Insider Trades & SAST Disclosures
Robert Tjian's most recent trade in Nurix Therapeutics Inc was a trade of 50,000 Series B Preferred Stock done . Disclosure was reported to the exchange on July 28, 2020.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Robert Tjian.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nurix Therapeutics Inc | Robert Tjian | Director | 28 Jul 2020 | 50,000 | 0 | - | - | Series B Preferred Stock | ||
| Nurix Therapeutics Inc | Robert Tjian | Director | 28 Jul 2020 | 50,000 | 124,999 | - | - | Common Stock | ||
| Nurix Therapeutics Inc | Robert Tjian | Director | 28 Jul 2020 | 41,666 | 0 | - | - | Series A-2 Preferred Stock | ||
| Nurix Therapeutics Inc | Robert Tjian | Director | 28 Jul 2020 | 41,666 | 74,999 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges